$CETXP

CEMTREX INC

CIK:0001435064|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenues	$ 18,440,210	$ 16,965,658	$ 52,634,888	$ 57,955,826
Cost of revenues	10,743,420	9,595,152	32,469,028	32,717,929
Gross profit	7,696,790	7,370,506	20,165,860	25,237,897
Operating expenses
General and administrative	8,464,742	7,626,342	24,863,716	21,490,373
Research and development	425,190	386,565	1,473,483	2,054,537
Total operating expenses	8,889,932	8,012,907	26,337,199	23,544,910
Operating (loss)/income	(1,193,142)	(642,401)	(6,171,339)	1,692,987
Other income/(expense)
Other income/(expense), net	87,678	68,002	221,830	(47,190)
Bargain purchase gain			2,068,047
Interest expense	(1,083,729)	(461,504)	(13,769,807)	(1,398,415)
Changes in fair value of digital assets	(127,264)		(1,225,705)
Unrealized loss on marketable Securities	(31,834)		(124,684)
Gain on Sale of marketable securities	52,952		52,952
Gain/(loss) on exercise of warrant liabilities	6,837	74,008	(4,651,745)	(15,722,097)
Changes in fair value of warrant liability	(2,199,991)	(3,615,437)	85,820	(8,928,275)
Total other income/(expense), net	(3,295,351)	(3,934,931)	(17,343,292)	(26,095,977)
Net loss before income taxes	(4,488,493)	(4,577,332)	(23,514,631)	(24,402,990)
Income tax (benefit)/expense	(119,001)	14,035	221,184	245,098
Loss from continuing operations	(4,369,492)	(4,591,367)	(23,735,815)	(24,648,088)
Loss from discontinued operations, net of tax	(110,000)	(42,280)	(392,776)	(282,599)
Net loss	(4,479,492)	(4,633,647)	(24,128,591)	(24,930,687)
Less net loss in noncontrolling interest				(180,152)
Less preferred stock dividends			46,918	21,949
Net loss attributable to Cemtrex, Inc. stockholders	$ (4,479,492)	$ (4,633,647)	$ (24,175,509)	$ (24,772,484)
Loss per share attributable to Cemtrex, Inc. stockholders - Basic and diluted
Income/(loss) per share - Continuing Operations - Basic	$ (3.19)	$ (5.16)	$ (22.99)	$ (27.63)
Income/(loss) per share - Discontinued Operations - Basic	(0.08)	(0.05)	(0.38)	(0.32)
Net Loss Per Share - Basic	(3.27)	(5.21)	(23.37)	(27.95)
Net Loss Per Share - Diluted	$ (3.27)	$ (5.21)	$ (23.37)	$ (27.95)
Weighted Average Number of Shares - Basic	1,371,250	890,432	1,034,475	886,336
Weighted Average Number of Shares - Diluted	1,371,250	890,432	1,034,475	886,336
Other comprehensive loss
Net loss	$ (4,479,492)	$ (4,633,647)	$ (24,128,591)	$ (24,930,687)
Foreign currency translation gain/(loss)	15,430	233,086	(16,306)	(321,835)
Comprehensive loss	(4,464,062)	(4,400,561)	(24,144,897)	(25,252,522)
Less net loss in noncontrolling interest				(180,152)
Comprehensive loss attributable to Cemtrex, Inc. stockholders	$ (4,464,062)	$ (4,400,561)	$ (24,144,897)	$ (25,072,370)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities
Net loss	$ (24,128,591)	$ (24,930,687)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	1,730,617	960,930
Loss on disposal of property and equipment	39,694	19,668
Noncash lease expense	886,942	684,360
Interest on finance leases	1,928
Loss on marketable securities	71,732
Credit loss expense	39,956	55,222
Loss on write-off of related party receivables	110,000
Contract modification - related party		280,545
Share-based compensation		10,280
Bargain purchase gain	(2,068,047)
Write-off of demonstration equipment	441,624
Interest expense paid in equity shares	12,269,120
Accrued interest on notes payable	511,568	803,030
Non-cash royalty income	(27,746)	(48,668)
Amortization of original issue discounts on notes payable	427,083	29,167
Loan origination costs	25,000	5,000
Receipt of SOL from staking	(47,704)
Non-cash transaction fees	10,285
Unrealized loss on digital assets	1,225,705
Loss on exercise of warrant liabilities	4,651,745	15,722,096
Changes in fair value of warrant liability	(85,820)	8,928,275
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:
Trade receivables	1,929,565	(1,534,474)
Trade receivables - related party	37,261	87,116
Inventory	(1,152,509)	1,162,286
Contract assets	(17,138)	387,056
Prepaid expenses and other current assets	(173,203)	(98,976)
Other assets	14,868	125,035
Accounts payable	(385,535)	295,378
Sales tax payable	(15,952)	(58,449)
Operating lease liabilities	(906,596)	(692,804)
Deposits from customers	161,589	(146,744)
Accrued expenses	(264,430)	60,159
Contract liabilities	180,922	1,455,386
Deferred revenue	(686,802)	(135,687)
Income taxes payable	292,337	(24,582)
Other liabilities	517	10,864
Net cash (used in)/provided by operating activities	(4,900,015)	3,410,782
Cash Flows from Investing Activities
Purchase of property and equipment	(966,783)	(1,435,743)
Proceeds from sale of property and equipment	17,133	13,511
Royalties on related party revenues	40,000	40,000
Purchase of marketable securities	(9,732,488)
Proceeds from sale of marketable securities	5,958,849
Acquisitions, net of cash acquired	(7,594,695)
Investment in digital assets	(1,000,567)
Investment in MasterpieceVR		(100,000)
Net cash used by investing activities	(13,278,551)	(1,482,232)
Cash Flows from Financing Activities
Proceeds on revolving line of credit	14,694,166	23,424,024
Payments on revolving line of credit	(15,873,476)	(24,509,177)
Payments on debt	(419,597)	(985,212)
Financing lease liabilities	(27,587)
Payments on Paycheck Protection Program Loans		(50,628)
Proceeds on Loan from CEO		200,000
Proceeds on bank loans		500,000
Proceeds from notes payable	7,000,000	1,307,354
Proceeds from warrant exercises	5,787,831
Proceeds from offerings	10,000,000	1,463,550
Expenses on offerings	(9,473)	(232,100)
Net cash provided by financing activities	21,151,864	1,117,811
Effect of currency translation	(18,599)	(321,394)
Net increase in cash, cash equivalents, and restricted cash	2,954,699	2,724,967
Cash, cash equivalents, and restricted cash at beginning of period	6,347,041	5,420,392
Total cash, cash equivalents, and restricted cash	9,301,740	8,145,359
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash
Cash and cash equivalents	7,972,128	7,032,530
Restricted cash	1,329,612	1,112,829
Supplemental Disclosure of Cash Flow Information:
Cash paid during the period for interest	562,036	1,777,081
Cash paid during the period for income taxes, net of refunds	78,305	237,943
Supplemental Schedule of Non-Cash Investing and Financing Activities
Shares issued to pay notes payable	21,211,561
Noncash dividends	136	252
Financing of Building Purchase	3,920,000
Financing of Acquisitions	600,000
Noncash recognition of new leases	983,114	720,104
Series A Warrant Exercises	211,098	21,515,777
Series B Warrant Exercises	$ 16,011,703	$ 1,386,169

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Sep. 30, 2025
Current assets
Cash and cash equivalents	$ 7,972,128	$ 4,974,303
Restricted cash	1,329,612	1,372,738
Marketable securities	3,701,907
Inventory, net	8,035,295	6,584,944
Contract assets, net	1,659,157	980,164
Prepaid expenses and other current assets	1,847,892	1,556,432
Total current assets	37,502,624	29,007,498
Property and equipment, net	16,612,511	9,651,996
Right-of-use operating lease assets	2,750,789	2,003,967
Right-of-use financing lease assets	38,010
Digital assets	970,519	1,158,238
Goodwill	7,686,141	3,708,347
Intangible assets, net of amortization	2,833,500
Other	1,611,263	2,067,755
Total Assets	70,005,357	47,788,276
Current liabilities
Accounts payable	4,877,828	4,492,859
Sales tax payable	60,056	76,008
Revolving line of credit	2,392,830	3,176,096
Current maturities of long-term liabilities	8,055,879	8,925,497
Operating lease liabilities - short-term	1,213,307	918,391
Financing lease liabilities - short-term	312,560
Deposits from customers	569,933	158,344
Accrued expenses	2,295,479	2,223,521
Accrued payable on inventory in transit	756,241	652,179
Contract liabilities	2,520,458	1,655,055
Deferred revenue	838,154	1,383,036
Accrued income taxes	454,510	162,173
Total current liabilities	24,347,235	23,823,159
Long-term liabilities
Long-term debt	8,577,988	4,586,779
Long-term operating lease liabilities	1,585,473	1,153,221
Other long-term liabilities	290,000	289,483
Deferred revenue - long-term	341,058	482,978
Warrant liabilities	2,866,152	8,735,197
Total long-term liabilities	13,660,671	15,247,658
Total liabilities	38,007,906	39,070,817
Commitments and contingencies
Stockholders’ equity
Common stock, $0.001 par value, 70,000,000 shares authorized, 1,259,716 shares issued and outstanding at June 30, 2026 and 23,413 shares issued and outstanding at September 30, 2025	1,260	83
Additional paid-in capital	153,092,747	105,669,313
Accumulated deficit	(123,526,332)	(99,397,741)
Treasury stock, 64,100 shares of Series 1 Preferred Stock at June 30, 2026, and September 30, 2025	(148,291)	(148,291)
Accumulated other comprehensive income	2,575,034	2,591,340
Total stockholders’ equity	31,997,451	8,717,459
Total liabilities and stockholders’ equity	70,005,357	47,788,276
Preferred Stock [Member]
Stockholders’ equity
Preferred stock, value	2,983	2,705
Series C Preferred Stock [Member]
Stockholders’ equity
Preferred stock, value	50	50
Nonrelated Party [Member]
Current assets
Trade receivables, net - related party	12,520,180	13,133,424
Related Party [Member]
Current assets
Trade receivables, net - related party	436,453	405,493
Royalties receivable, net - related party		$ 190,475